Huntington Ingalls (HII) came out with quarterly earnings of $3.68 per share, beating the Zacks Consensus Estimate of $3.29 per share. This compares to earnings of $2.56 per share a year ago.

Sirius XM (SIRI) came out with quarterly earnings of $0.84 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to a loss of $0.84 per share a year ago.

Upbound Group (UPBD) came out with quarterly earnings of $1 per share, beating the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $0.95 per share a year ago.

Crocs (CROX) came out with quarterly earnings of $2.92 per share, beating the Zacks Consensus Estimate of $2.39 per share. This compares to earnings of $3.6 per share a year ago.

Eli Lilly (NYSE: LLY) delivered a commanding third quarter, posting earnings and revenue that significantly exceeded expectations while raising full-year guidance.

DocuSign (DOCU) is rated Buy with a $81 price target, offering 14% upside potential and market outperformance over the next 12 months. DOCU trades at a 25% discount to sector median P/E, despite exceptional 83.8% subscription gross margins and consistent double-beat quarters. International revenue growth (13% YoY, now 29% of total) and strong partnerships with major tech firms support a bullish outlook for DOCU.

Further Upsized from $65 Million Due to Strong Demand Vancouver, British Columbia--(Newsfile Corp. - October 30, 2025) - NexMetals Mining Corp. (TSXV: NEXM) (NASDAQ: NEXM) (the "Company" or "NEXM") is pleased to announce that it has increased the size of its previously announced "best efforts" public offering (the "Offering") of units of the Company ("Units") from up to C$65,000,000 to up to C$80,000,000 due to strong demand from institutional investors, representing the second time the offering has been upsized. The Offering will be conducted by certain agents as co-lead agents, on their own behalf and on behalf of a syndicate …

Neve Yarak, Israel, Oct. 30, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a cleantech company investing in solar energy assets based on the RTB (Ready to Build) business model, recently announced the closing of the merger with MitoCareX Bio Ltd. ("MitoCareX"), a biotech company focused on drug discovery targeting cancer therapeutics, with a range of other potential diseases and disorders, through targeting the mitochondrial SLC25 protein family.

Further Upsized from $65 Million Due to Strong Demand Vancouver, British Columbia--(Newsfile Corp. - October 30, 2025) - NexMetals Mining Corp. (TSXV: NEXM) (NASDAQ: NEXM) (the "Company" or "NEXM") is pleased to announce that it has increased the size of its previously announced "best efforts" public offering (the "Offering") of units of the Company ("Units") from up to C$65,000,000 to up to C$80,000,000 due to strong demand from institutional investors, representing the second time the offering has been upsized. The Offering will be conducted by SCP Resource Finance LP as sole bookrunner and together with Raymond James Ltd as co-lead …

Broadcom NASDAQ: AVGO has raked in a lot of positive news in 2025. This includes posting multiple impressive earnings reports and its 10-gigawatt (GW) artificial intelligence (AI) chip deal with ChatGPT maker OpenAI.

Crude oil softened early Thursday, hovering near $60 amid concerns over sluggish demand and persistent oversupply. Despite new sanctions on Russia, the market's outlook remains weak, with resistance seen near $62–$67 and $60 acting as key support.

Merck published its financial results for Q3 2025 this morning. Strong demand for Winrevair from patients suffering from pulmonary arterial hypertension drove sales to $360 million in the third quarter of 2025, up 141.6% year-on-year. Of MRK's vaccine franchise, its "gem" remains Capvaxive, which generated sales of $244 million for the quarter, a sharp 419.1% rise from the same period a year ago.

WMT's digital expansion and COST's loyal membership base highlight two powerful yet distinct retail growth stories.

AEM's Q3 profit soared on stronger gold prices, with earnings and revenue surpassing estimates and full-year guidance reaffirmed.

CCC Intelligent Solutions Holdings Inc. (CCCS) came out with quarterly earnings of $0.09 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.1 per share a year ago.

Malibu Boats (MBUU) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.08 per share a year ago.

Myers (MYE) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.25 per share a year ago.

Insmed (INSM) came out with a quarterly loss of $1.75 per share versus the Zacks Consensus Estimate of a loss of $1.32. This compares to a loss of $1.27 per share a year ago.

S&P Global (SPGI) came out with quarterly earnings of $4.73 per share, beating the Zacks Consensus Estimate of $4.4 per share. This compares to earnings of $3.89 per share a year ago.

NovoCure (NVCR) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to a loss of $0.28 per share a year ago.